CLINICAL TRIALS PROFILE FOR PAMELOR
✉ Email this page to a colleague
All Clinical Trials for PAMELOR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00062738 ↗ | Treatment of Depression in Parkinson's Disease Trial | Completed | GlaxoSmithKline | Phase 2 | 2003-06-01 | The goal of this study is to evaluate the effectiveness and safety of two antidepressants--nortriptyline and paroxetine, compared to placebo in patients with Parkinson's disease and depression. |
NCT00062738 ↗ | Treatment of Depression in Parkinson's Disease Trial | Completed | Rutgers, The State University of New Jersey | Phase 2 | 2003-06-01 | The goal of this study is to evaluate the effectiveness and safety of two antidepressants--nortriptyline and paroxetine, compared to placebo in patients with Parkinson's disease and depression. |
NCT00547703 ↗ | Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia | Terminated | Cleveland Clinic Florida | N/A | 2008-02-01 | The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia. |
NCT00547703 ↗ | Effect of Nortriptyline on Abdominal Pain/Discomfort and Quality of Life in Patients With Nonulcer Dyspepsia | Terminated | The Cleveland Clinic | N/A | 2008-02-01 | The purpose of this study is to determine if use of Nortriptyline will improve symptoms and quality of life in patients who have nonulcer dyspepsia. |
NCT00742573 ↗ | Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics | Completed | National Institute of Mental Health (NIMH) | Phase 2 | 2008-08-01 | This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder. |
NCT00742573 ↗ | Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics | Completed | New York State Psychiatric Institute | Phase 2 | 2008-08-01 | This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PAMELOR
Condition Name
Clinical Trial Locations for PAMELOR
Trials by Country
Clinical Trial Progress for PAMELOR
Clinical Trial Phase
Clinical Trial Sponsors for PAMELOR
Sponsor Name
Sponsor Name for PAMELOR | |
Sponsor | Trials |
National Institute of Mental Health (NIMH) | 2 |
New York State Psychiatric Institute | 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
[disabled in preview] | 3 |
This preview shows a limited data set Subscribe for full access, or try a Trial |